EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum

Helena Gossye, Sara Van Mossevelde, Anne Sieben, Maria Bjerke, Elisabeth Hendrickx Van de Craen, Julie van der Zee, Peter P De Deyn, Jan De Bleecker, Jan Versijpt, Jenneke van den Ende, Olivier Deryck, Paul Bourgeois und 5 weitere

Brain · 2023

DOI: 10.1093/brain/awac362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Helena Gossye und 16 weiteren Autor:innen. Beteiligte Einrichtung: VIB Center for Molecular Neurology, 2610 Antwerp, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, Frontotemporal Dementia, Frontotemporal Lobar Degeneration, Pick Disease of the Brain. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Flemish Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The missense mutation p.R406W in microtubule-associated protein tau leads to frontotemporal lobar degeneration with an amnestic, Alzheimer’s disease-like phenotype with an autosomal dominant pattern of inheritance. In 2003, we described the pedigree of a Belgian family, labelled ADG, with 28 p.R406W patients. Over 18 years follow-up, we extended the family with 10 p.R406W carriers and provided an in-depth clinical description of the patients. Additionally, genetic screening was used to identify p.R406W carriers in Belgian cohorts of frontotemporal dementia and Alzheimer’s disease patients and to calculate p.R406W frequency. In the frontotemporal dementia cohort, we found four p.R406W carriers (n = 647, 0.62%) and three in the Alzheimer’s disease cohort (n = 1134, 0.26%). Haplotype sharing analysis showed evidence of a shared haplotype suggesting that they are descendants of a common ancestor. Of the p.R406W patients, we describe characteristics of neuropsychological, imaging and fluid biomarkers as well as neuropathologic examination. Intriguingly, the phenotypic spectrum among the p.R406W patients ranged from typical behavioural variant frontotemporal dementia to clinical Alzheimer’s disease, based on CSF biomarker analysis and amyloid PET scan. Heterogeneous overlap syndromes existed in between, with highly common neuropsychiatric symptoms like disinhibition and aggressiveness, which occurred in 100% of frontotemporal dementia and 58% of clinical Alzheimer’s disease patients. This was also the case for memory problems, 89% in frontotemporal dementia and 100% in clinical Alzheimer’s disease patients. Median age at death was significantly lower in patients with frontotemporal dementia (68 years) compared to clinical Alzheimer’s disease patients (79 years), although the sizes of the sub-cohorts are limited and do not allow prognostic predictions. Post-mortem brain analysis of one p.R406W patient with behavioural variant frontotemporal dementia revealed frontotemporal lobar degeneration with tau pathology. Notably, neuropathological investigation showed only 3R tau isoforms in the absence of 4R tau reactivity, an unusual finding in microtubule-associated protein tau-related frontotemporal lobar degeneration. No traces of amyloid pathology were present. Prevalence of the p.R406W mutation was relatively high in both frontotemporal dementia and Alzheimer’s disease Belgian patient cohorts. These findings grant new insights into genotype–phenotype correlations of p.R406W carriers. They may help in further unravelling of the pathophysiology of this tauopathy and in facilitating the identification of patients with p.R406W-related frontotemporal lobar degeneration, both in clinical diagnostic and research settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseFrontotemporal DementiaFrontotemporal Lobar DegenerationPick Disease of the BrainHumanstau ProteinsMutationPhenotypeBiomarkers

Stichwörter der Autor:innen

MAPTAlzheimer’s diseasefrontotemporal dementiagenotype–phenotype correlationstauopathy

Substanzen

tau ProteinsBiomarkersMAPT protein, human

Autor:innen und Institutionen

  • VIB Center for Molecular Neurology, 2610 Antwerp, Belgium.
  • Department of Neurology, University Hospital Antwerp, 2650 Edegem, Belgium.
  • Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.
  • Institute Born-Bunge, 2610 Antwerp, Belgium.
  • Department of Neurology and Memory Clinic, Hospital Network Antwerp, 2000 Antwerp, Belgium.
  • Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.

ORCID-Profile: Rik Vandenberghe, Sebastiaan Engelborghs, Christine Van Broeckhoven

Förderung

  • Flemish Government

Zitieren

APA

Gossye, H., Van Mossevelde, S., Sieben, A., Bjerke, M., Hendrickx Van de Craen, E., van der Zee, J., De Deyn, P. P., De Bleecker, J., Versijpt, J., van den Ende, J., Deryck, O., Bourgeois, P., Bier, J. C., Goethals, M., Vandenberghe, R., Engelborghs, S., & Van Broeckhoven, C. (2023). Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum. Brain. https://doi.org/10.1093/brain/awac362

Vancouver

Gossye H, Van Mossevelde S, Sieben A, Bjerke M, Hendrickx Van de Craen E, van der Zee J, et al. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum. Brain. 2023. doi:10.1093/brain/awac362

BibTeX
@article{Gossye2023,
  author = {Gossye, Helena and Van Mossevelde, Sara and Sieben, Anne and Bjerke, Maria and Hendrickx Van de Craen, Elisabeth and van der Zee, Julie and De Deyn, Peter P and De Bleecker, Jan and Versijpt, Jan and van den Ende, Jenneke and Deryck, Olivier and Bourgeois, Paul and Bier, Jean-Christophe and Goethals, Maarten and Vandenberghe, Rik and Engelborghs, Sebastiaan and Van Broeckhoven, Christine},
  title = {Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum},
  journal = {Brain},
  year = {2023},
  doi = {10.1093/brain/awac362}
}
Kostenlos starten →